MB
Mark Breidenbach Oppenheimer Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Nurix Therapeutics
NRIX
$742M
| $9.20 | $30 |
226%
upside
| Outperform |
4 Sep ‘24
1 year ago |
|
2
Allogene Therapeutics
ALLO
$253M
| $1.14 | $13 |
1,040%
upside
| Outperform |
21 May ‘24
1 year ago |
|
3
ESSA Pharma
EPIX
$11.2M
| $0.2400 | $17 |
6,983%
upside
| Outperform |
13 Dec ‘23
1 year ago |
|
4
Arvinas
ARVN
$583M
| $8 | $95 |
1,088%
upside
| Outperform |
9 Aug ‘23
2 years ago |
|
5
Immuneering
IMRX
$247M
| $7.05 | $25 |
255%
upside
| Outperform |
8 Aug ‘23
2 years ago |
|
6
Cue Biopharma
CUE
$59.7M
| $0.7709 | $10 |
1,197%
upside
| Outperform |
26 Jun ‘23
2 years ago |
|
7
Seres Therapeutics
MCRB
$200M
| $18.64 | $240 |
1,188%
upside
| Outperform |
26 Jun ‘23
2 years ago |
|
|
BLRX
8
BioLineRX
BLRX
$15.5M
| $3.65 | $160 |
4,284%
upside
| Outperform |
25 May ‘23
2 years ago |
|
9
Compugen
CGEN
$136M
| $1.43 | $7 |
390%
upside
| Outperform |
16 May ‘23
2 years ago |
|
10
Caribou Biosciences
CRBU
$169M
| $1.84 | $32 |
1,639%
upside
| Outperform |
10 Mar ‘23
2 years ago |
|
11
Iovance Biotherapeutics
IOVA
$861M
| $2.37 | $15 |
533%
upside
| Outperform |
1 Mar ‘23
2 years ago |
|
12
Synlogic
SYBX
$17.2M
| $1.46 | $120 |
8,119%
upside
| Outperform |
18 Oct ‘22
2 years ago |
|
13
Mustang Bio
MBIO
$9.85M
| $1.47 | $9,750 |
663,165%
upside
| Outperform |
12 May ‘20
5 years ago |
|